Vault-13

Camber Capital Management LP

BOSTON, MA · CIK 1444043 · 13F filing filed 2023-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$3.1bn reported value +4.8% vs Q1 2023
38positions
63.1%in top 10
2 new 11 added 8 reduced 4 sold out vs Q1 2023

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 UNIVERSAL HLTH SVCS INC CL B UHS UHS 1,925,000 $303.7m9.89% 9.89% UnchangedShares held: Q3 2022 2.2m, Q4 2022 1.7m, Q1 2023 1.9m, Q2 2023 1.9m
2 TENET HEALTHCARE CORP COM NEW THC THC 3,200,000 $260.4m8.48% 8.48% ReducedShares held: Q3 2022 3.0m, Q4 2022 4.0m, Q1 2023 3.9m, Q2 2023 3.2m -650.0k -650,000 -16.9%
3 VIATRIS INC COM VTRS VTRS 22,500,000 $224.6m7.31% 7.31% UnchangedShares held: Q3 2022 30.0m, Q4 2022 20.0m, Q1 2023 22.5m, Q2 2023 22.5m
4 SANOFI SPONSORED ADR SNY SNY 4,000,000 $215.6m7.02% 7.02% ReducedShares held: Q3 2022 7.5m, Q4 2022 7.0m, Q1 2023 5.5m, Q2 2023 4.0m -1.5m -1,500,000 -27.3%
5 WALGREENS BOOTS ALLIANCE INC COM WBA WBA 7,500,000 $213.7m6.96% 6.96% AddedShares held: Q3 2022 2.8m, Q4 2022 5.0m, Q1 2023 6.5m, Q2 2023 7.5m +1.0m +1,000,000 15.4%
6 MYRIAD GENETICS INC COM MYGN MYGN 6,635,000 $153.8m5.01% 5.01% ReducedShares held: Q3 2022 5.0m, Q4 2022 7.0m, Q1 2023 7.0m, Q2 2023 6.6m -365.0k -365,000 -5.2%
7 ZIMMER BIOMET HOLDINGS INC COM ZBH ZBH 1,050,000 $152.9m4.98% 4.98% ReducedShares held: Q3 2022 1.4m, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 1.1m -200.0k -200,000 -16.0%
8 GSK PLC SPONSORED ADR GSK GSK 4,100,000 $146.1m4.76% 4.76% ReducedShares held: Q3 2022 2.5m, Q4 2022 3.8m, Q1 2023 4.6m, Q2 2023 4.1m -500.0k -500,000 -10.9%
9 BAXTER INTL INC COM BAX BAX 3,000,000 $136.7m4.45% 4.45% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 3.0m, Q2 2023 3.0m
10 SELECT MED HLDGS CORP COM SEM SEM 4,050,000 $129.0m4.20% 4.20% ReducedShares held: Q3 2022 4.8m, Q4 2022 4.8m, Q1 2023 4.8m, Q2 2023 4.0m -750.0k -750,000 -15.6%
11 IONIS PHARMACEUTICALS INC COM IONS IONS 2,500,000 $102.6m3.34% 3.34% AddedShares held: Q3 2022 1.9m, Q4 2022 1.9m, Q1 2023 1.9m, Q2 2023 2.5m +575.0k +575,000 29.9%
12 PTC THERAPEUTICS INC COM PTCT PTCT 2,500,000 $101.7m3.31% 3.31% UnchangedShares held: Q3 2022 2.5m, Q4 2022 2.8m, Q1 2023 2.5m, Q2 2023 2.5m
13 PERRIGO CO PLC SHS PRGO PRGO 2,500,000 $84.9m2.76% 2.76% UnchangedShares held: Q3 2022 2.5m, Q4 2022 2.5m, Q1 2023 2.5m, Q2 2023 2.5m
14 QUANTERIX CORP COM QTRX QTRX 3,425,000 $77.2m2.51% 2.51% UnchangedShares held: Q3 2022 3.0m, Q4 2022 3.4m, Q1 2023 3.4m, Q2 2023 3.4m
15 BROOKDALE SR LIVING INC COM BKD BKD 18,000,000 $76.0m2.47% 2.47% UnchangedShares held: Q3 2022 16.0m, Q4 2022 18.0m, Q1 2023 18.0m, Q2 2023 18.0m
16 DENTSPLY SIRONA INC COM XRAY XRAY 1,765,000 $70.6m2.30% 2.30% UnchangedShares held: Q3 2022 1.4m, Q4 2022 1.8m, Q1 2023 1.8m, Q2 2023 1.8m
17 MIRATI THERAPEUTICS INC COM MRTX MRTX 1,800,000 $65.0m2.12% 2.12% AddedShares held: Q3 2022 2.0m, Q4 2022 1.4m, Q1 2023 1.4m, Q2 2023 1.8m +400.0k +400,000 28.6%
18 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 8,500,000 $64.0m2.08% 2.08% AddedShares held: Q3 2022 7.5m, Q4 2022 7.0m, Q1 2023 3.0m, Q2 2023 8.5m +5.5m +5,500,000 183.3%
19 GLOBUS MED INC CL A GMED GMED 1,000,000 $59.5m1.94% 1.94% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 305.0k, Q2 2023 1.0m +695.0k +695,000 227.9%
20 MEDTRONIC PLC SHS MDT MDT 600,000 $52.9m1.72% 1.72% NewShares held: Q3 2022 500.0k, Q4 2022 0, Q1 2023 0, Q2 2023 600.0k
21 SAREPTA THERAPEUTICS INC COM SRPT SRPT 400,000 $45.8m1.49% 1.49% ReducedShares held: Q3 2022 1.5m, Q4 2022 1.2m, Q1 2023 750.0k, Q2 2023 400.0k -350.0k -350,000 -46.7%
22 ZIMVIE INC COM ZIMV ZIMV 3,250,000 $36.5m1.19% 1.19% UnchangedShares held: Q3 2022 2.6m, Q4 2022 2.6m, Q1 2023 3.2m, Q2 2023 3.2m
23 HERBALIFE LTD COM SHS HLF HLF 2,750,000 $36.4m1.19% 1.19% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 825.0k, Q2 2023 2.8m +1.9m +1,925,000 233.3%
24 REPLIMUNE GROUP INC COM REPL REPL 1,550,000 $36.0m1.17% 1.17% AddedShares held: Q3 2022 0, Q4 2022 1.0m, Q1 2023 1.2m, Q2 2023 1.6m +300.0k +300,000 24.0%
25 EXELIXIS INC COM EXEL EXEL 1,550,000 $29.6m0.96% 0.96% UnchangedShares held: Q3 2022 1.4m, Q4 2022 1.4m, Q1 2023 1.6m, Q2 2023 1.6m
26 CENTENE CORP DEL COM CNC CNC 400,000 $27.0m0.88% 0.88% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 400.0k, Q2 2023 400.0k
27 PELOTON INTERACTIVE INC CL A COM PTON PTON 3,000,000 $23.1m0.75% 0.75% AddedShares held: Q3 2022 3.0m, Q4 2022 2.0m, Q1 2023 750.0k, Q2 2023 3.0m +2.2m +2,250,000 300.0%
28 COLLEGIUM PHARMACEUTICAL INC COM COLL COLL 1,050,000 $22.6m0.73% 0.73% UnchangedShares held: Q3 2022 1.1m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.1m
29 ORASURE TECHNOLOGIES INC COM OSUR OSUR 4,250,000 $21.3m0.69% 0.69% UnchangedShares held: Q3 2022 4.2m, Q4 2022 4.2m, Q1 2023 4.2m, Q2 2023 4.2m
30 BROOKDALE SR LIVING INC UNIT 11/15/2025 BKD 7 11.15.25 BKD 7 11.15.25 250,000 $15.5m0.50% 0.50% UnchangedShares held: Q3 2022 0, Q4 2022 250.0k, Q1 2023 250.0k, Q2 2023 250.0k
31 CUREVAC N V COM CVAC CVAC 1,462,500 $15.2m0.50% 0.50% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.2m, Q2 2023 1.5m +212.5k +212,500 17.0%
32 PUMA BIOTECHNOLOGY INC COM PBYI PBYI 4,235,000 $14.9m0.49% 0.49% UnchangedShares held: Q3 2022 4.2m, Q4 2022 4.2m, Q1 2023 4.2m, Q2 2023 4.2m
33 THE BEAUTY HEALTH COMPANY COM CL A COM CL A 1,750,000 $14.6m0.48% 0.48% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 500.0k, Q2 2023 1.8m +1.2m +1,250,000 250.0%
34 INOGEN INC COM INGN INGN 1,150,000 $13.3m0.43% 0.43% AddedShares held: Q3 2022 825.0k, Q4 2022 305.0k, Q1 2023 975.0k, Q2 2023 1.1m +175.0k +175,000 17.9%
35 GLAUKOS CORP COM GKOS GKOS 160,000 $11.4m0.37% 0.37% ReducedShares held: Q3 2022 350.0k, Q4 2022 350.0k, Q1 2023 350.0k, Q2 2023 160.0k -190.0k -190,000 -54.3%
36 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 1,418,439 $7.4m0.24% 0.24% UnchangedShares held: Q3 2022 0, Q4 2022 1.4m, Q1 2023 1.4m, Q2 2023 1.4m
37 CANO HEALTH INC COM CL A COM CL A 4,000,000 $5.6m0.18% 0.18% UnchangedShares held: Q3 2022 5.0m, Q4 2022 4.0m, Q1 2023 4.0m, Q2 2023 4.0m
38 DYNAVAX TECHNOLOGIES CORP COM NEW DVAX DVAX 300,000 $3.9m0.13% 0.13% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 300.0k

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
CONMED CORP CNMD CNMD 325,000 $33.8m325.0k shares
NUVASIVE INC NUVA NUVA 600,000 $24.8m600.0k shares
ALIGN TECHNOLOGY INC ALGN ALGN 50,000 $16.7m50.0k shares
NANOSTRING TECHNOLOGIES INC NSTG NSTG 1,500,000 $14.8m1.5m shares